ADVFN Logo ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Registration Strip Icon for charts Registrieren Sie sich für Echtzeit-Charts, Analysetools und Preise.
Eagle Capital Growth Fund Inc

Eagle Capital Growth Fund Inc (GRF)

10,50
0,00
( 0,00% )
Aktualisiert: 19:48:57

Ihr Hub für Echtzeit-Streaming-Zitate, Ideen und Live-Diskussionen

Wichtige Statistiken und Details

Current Price
10,50
Gebot
-
Fragen
-
Volumen
116
10,20 Tagesbereich 10,70
7,93 52-Wochen-Bereich 10,99
Marktkapitalisierung
Handelsende
10,50
Handelsbeginn
10,20
Letzte Trade
1
@
10.417022
Letzter Handelszeitpunkt
18:24:44
Finanzvolumen
US$ 1.218
VWAP
10,50
Durchschnittliches Volumen (3 Mio.)
3.766
Ausgegebene Aktien
3.967.836
Dividendenrendite
3.33%
Kurs-Gewinn-Verhältnis
9,03
Gewinn pro Aktie (EPS)
1,16
Erlöse
736k
Nettogewinn
4,61M

Über Eagle Capital Growth Fund Inc

The Fund's objective is long-term growth utilizing the concept of total return for selecting investments. The Fund's objective is long-term growth utilizing the concept of total return for selecting investments.

Sektor
Unit Inv Tr, Closed-end Mgmt
Branche
Unit Inv Tr, Closed-end Mgmt
Hauptsitz
Lutherville Timonium, Maryland, USA
Gegründet
-
Eagle Capital Growth Fund Inc is listed in the Unit Inv Tr, Closed-end Mgmt sector of the Amerikanische Börse with ticker GRF. The last closing price for Eagle Capital Growth was US$10,50. Over the last year, Eagle Capital Growth shares have traded in a share price range of US$ 7,93 to US$ 10,99.

Eagle Capital Growth currently has 3.967.836 shares in issue. The market capitalisation of Eagle Capital Growth is US$41,66 million. Eagle Capital Growth has a price to earnings ratio (PE ratio) of 9.03.

GRF Neueste Nachrichten

GigaGen Doses First Patient in Phase 1 Trial of Recombinant Polyclonal Drug Candidate, GIGA-2339, for Hepatitis B Virus

SAN CARLOS, Calif., Nov. 19, 2024 (GLOBE NEWSWIRE) -- GigaGen Inc., a biotechnology company advancing transformative antibody drugs for immunodeficiencies, infectious diseases and...

Eagle Capital Growth Fund Declares Year-End Distribution of $0.68 Per Share in Cash

The Eagle Capital Growth Fund, Inc. (“Fund”) (NYSE American: GRF) today declared a year-end distribution of $0.68 per share in cash. The record date for this distribution is November 29, 2024...

Grifols Receives FDA Approval to Treat Surgical Bleeding in Pediatric Patients With its Fibrin Sealant Solution

Younger patients in the U.S. can now benefit from Grifols Fibrin Sealant (FS) and its positive effect on surgical outcomes, including a fast time to hemostasisGrifols surgical bleeding management...

Grifols Partners with BARDA for Proof-of-Concept Testing of Ocular Immunoglobulin as Treatment for Sulfur Mustard-Induced Eye Injury

Initiative will test Grifols ocular surface immunoglobulin (OSIG) eye drops to evaluate their nonclinical efficacy in neutralizing symptoms from exposure to sulfur mustard, a chemical warfare...

GigaGen Awarded U.S. BARDA Contract to Develop Recombinant Polyclonal Antibody Therapies for Botulinum Neurotoxins and an Additional Biothreat

The contract will provide an initial commitment of $19.6 million and up to $135.2 million over a six-year period, supporting drug manufacturing and phase 1 trials for the two programs GigaGen’s...

Zeitraum †ÄnderungÄnderung %HandelsbeginnHochNiedrigDurchsch. VolumenVWAP
10.363.5502958579910.1410.999.85347910.38489847CS
40.595.953582240169.9110.999.79289410.12145722CS
121.0711.34676564169.4310.999.4237669.84935092CS
261.2213.14655172419.2810.999.0430439.66597517CS
522.0624.40758293848.4410.997.9331709.4296203CS
1561.6318.37655016918.8711.257.846199.11104039CS
2603.0540.93959731547.4511.255.248998.44606376CS
  • Volumen
  • % Tops
  • % Flops
SymbolPreisVol.
BIGYYieldmax Target 12 Big 50 Option Income ETF
 50,22
(177,61%)
14,96k
SNOYYieldmax Snow Option Income Strategy ETF
US$ 22,26
(26,77%)
54,17k
HYLNHyliion Holdings Corp
US$ 3,585
(23,20%)
3,05M
MGLDMarygold Companies Inc
US$ 1,47
(22,50%)
47,43k
ETHU2x Ether ETF
US$ 8,8199
(19,35%)
31,43M
CATXPerspective Therapeutics Inc
US$ 3,2187
(-47,83%)
8,81M
ETHDProshares Ultrashort Ether ETF
US$ 25,40
(-19,21%)
113,24k
ETQT Rex 2X Inverse Ether Daily Target ETF
US$ 11,54
(-18,24%)
6,29k
ROLRHigh Roller Technologies Inc
US$ 6,05
(-16,55%)
19,85k
MSTYYieldMax MSTR Option Income Strategy ETF
US$ 38,22
(-13,92%)
5,85M
MSTZT Rex 2X Inverse MSTR Daily Target ETF
US$ 0,87
(7,04%)
1,1B
SOXLDirexion Daily Semiconductor Bull 3X Shares
US$ 28,725
(5,88%)
74,91M
SPXSDirexion Daily S&P 500 Bear 3X Shares New
US$ 6,065
(-1,86%)
63,36M
NVDQT Rex 2X Inverse NVIDIA Daily Target ETF
US$ 3,0188
(-1,35%)
60,9M
SOXSDirexion Daily Semiconductor Bear 3X Shares New
US$ 23,20
(-5,81%)
31,64M
Keine Diskussionen Gefunden.
Neuen Thread Erstellen

Kürzlich von Ihnen besucht

Delayed Upgrade Clock